Robot suit could help kids with cerebral palsy walk stronger

NCT ID NCT05726591

Recruiting now Disease control Sponsor: National Institutes of Health Clinical Center (CC) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a wearable robotic exoskeleton designed to improve walking in children aged 3 to 17 with conditions like cerebral palsy, spina bifida, muscular dystrophy, or incomplete spinal cord injury. The device fits on the legs and can assist or resist movement during walking. Over three 12-week phases, participants will compare their usual therapy with lab-based exoskeleton training and home use of the device. The goal is to see if long-term use improves knee motion and walking speed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pediatric robotic exoskeleton (P.REX/Agilik)
What this could lead to: If it works, this could provide a new way to improve walking ability and knee movement in children with certain movement disorders.
What could go wrong: This is an early-phase trial with only 44 participants, so results may not apply to all children. The device may be uncomfortable or not improve walking for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral palsy muscular dystrophy spina bifida spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL PALSY INCOMPLETE SPINAL CORD INJURY MUSCULAR DYSTROPHY SPINA BIFIDA

Contacts and locations

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.